Glutathione Dosage: Clinical Evidence & Provider Guidelines

Last reviewed: May 28, 2026

Last updated: May 28, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Glutathione dosage recommendations range from 250 mg to 2,000 mg daily depending on route, indication, and individual factors, with intravenous protocols typically higher than oral formulations. Clinical evidence suggests optimal dosing requires assessment of baseline glutathione status and metabolic capacity.

For individuals exploring precision-wellness approaches, understanding how genetic and biomarker factors influence antioxidant metabolism can support more informed conversations with healthcare providers about dosing strategy. This personalized perspective helps move beyond generic recommendations.

Glutathione Dosage by Route: Absorption and Efficacy Differences

Oral glutathione bioavailability remains limited due to gastrointestinal degradation; typical oral doses range 250–500 mg daily, though some protocols use up to 1,000 mg divided doses. Liposomal and acetylated formulations may enhance absorption compared to standard oral tablets.

Intravenous glutathione protocols typically employ 1,000–2,000 mg per infusion, administered 1–3 times weekly, based on clinical indication and institutional practice. Intranasal and nebulized formulations represent emerging routes with variable dosing evidence.

Glutathione Dosing Across Clinical Conditions and Evidence

Glutathione dosing varies significantly by clinical application. Evidence-based ranges exist for antioxidant support, neurological conditions, and metabolic optimization, though provider assessment remains essential for determining individual appropriateness.

Clinical Context	Typical Dosage Range	Route(s)	Key Consideration
General antioxidant support	250–500 mg daily	Oral (liposomal preferred)	Bioavailability limits efficacy; quality formulation matters
Athletic performance/recovery	500–1,000 mg daily	Oral or IV weekly	Glutathione depletion with intense training; evidence moderate
Neurological/cognitive support	600–1,200 mg daily	Oral or IV protocol	Mechanism involves antioxidant and mitochondrial support; individualized need
Detoxification protocols	1,000–2,000 mg IV	Intravenous (1–3×/week)	Higher doses bypass GI absorption; provider monitoring recommended

Individual Factors Influencing Optimal Glutathione Dosage

Baseline glutathione levels, antioxidant enzyme capacity, age, and genetic variations in phase II detoxification genes influence how much glutathione an individual can metabolize effectively. Chronic illness, oxidative stress, and medications deplete glutathione and may require higher replacement doses.

Genetic variants affecting glutathione synthase and related enzymes influence cellular glutathione production and may predict response to supplemental dosing. Provider-ordered biomarker assessment helps establish baseline status and guide titration decisions.

Safety, Monitoring, and Provider-Guided Dosage Adjustment

Glutathione is generally well-tolerated, though high oral doses may cause gastrointestinal discomfort. Intravenous protocols require provider supervision due to infusion risks, potential reactions, and need for ongoing monitoring of therapeutic response.

Dosage should begin conservatively and adjust based on tolerance and clinical markers. Concurrent medications, liver function, and kidney health influence dosing safety. Regular provider review ensures continued appropriateness and detects potential interactions or adverse effects.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context around individual genetic variations in antioxidant enzyme pathways and cellular metabolism, supporting a more informed discussion about whether supplemental glutathione aligns with a person's metabolic profile.

The genetic test reveals predispositions in cellular antioxidant defense pathways, including variants affecting glutathione metabolism. This information should be interpreted with a qualified healthcare provider to contextualize how genetic factors may relate to individual glutathione status and need.

Understanding genetic predispositions in antioxidant metabolism can support a more personalized conversation with a provider about whether glutathione supplementation is appropriate, at what dosage, and in what formulation—moving beyond one-size-fits-all recommendations toward precision-wellness strategies.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the standard glutathione dosage for general wellness?

Typical oral dosages range 250–500 mg daily for general antioxidant support, though bioavailability is limited. Liposomal formulations may improve absorption. Provider guidance helps determine individual appropriateness and optimal dosing.

Is intravenous glutathione more effective than oral forms?

IV glutathione bypasses GI degradation and achieves higher bioavailable concentrations, making it potentially more effective for certain clinical goals. However, oral liposomal forms offer convenience. Route choice depends on indication and provider assessment.

How does genetic variation affect glutathione dosing needs?

Genetic variants in antioxidant enzyme genes (glutathione synthase, GPX, SOD) influence cellular glutathione production capacity. PlexusDx's Precision Peptide Genetic Test reveals predispositions in these pathways to support personalized discussions with providers about dosing strategy.

Are there safety concerns with high-dose glutathione?

High oral doses may cause GI upset; IV protocols require medical supervision. Long-term safety data is limited. Provider monitoring ensures dosages remain appropriate and detects potential interactions with medications or underlying conditions.

How often should glutathione dosage be reassessed?

Dosage should be reviewed every 4–8 weeks initially to assess tolerance and response. Baseline biomarker assessment can guide titration. Ongoing provider oversight helps optimize dosing as clinical status or health goals change.

Glutathione Dosage: Clinical Context and Personalized Optimization

Glutathione dosage varies widely based on clinical indication, route of administration, and individual metabolic factors. Effective dosing requires provider guidance to balance therapeutic benefit with safety considerations.